Precision Gene Delivery by SHREAD VLPs for Enhanced Safety and Efficacy In Vivo

Time: 1:00 pm
day: Day 1


• Overview of Vector BioPharma’s proprietary SHielded Retargeted ADenovirus (SHREAD)-based virus-like particle (VLP) technology and key applications in cell therapy, immuno-oncology, genome editing and beyond

• Interchangeable adapter technology for targeting VLP to specific tissues and cell types in vivo

• Shielding and capsid engineering technologies for reducing immunogenicity and clearance of VLPs